Sonoanatomy relevant for lumbar plexus block in volunteers correlated with cross-sectional anatomic and magnetic resonance images

Regional Anesthesia and Pain Medicine

Volumn 38, Issue 5, 2013, Pages 391-397

  Karmakar, Manoj Kumar ^a   Li, Jia Wei ^a   Kwok, Wing Hong ^a   Soh, Edmund ^b   Hadzic, Admir ^c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b ALEXANDRA HOSPITAL   (Singapore)

^c St Luke's and Roosevelt Hospitals ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANATOMIC LANDMARK; ARTICLE; CADAVER; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; ECHOGRAPHY; FEASIBILITY STUDY; FEMALE; HUMAN; LIKERT SCALE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPINAL ROOT; VISIBILITY;

HUMANS; LUMBOSACRAL PLEXUS; MAGNETIC RESONANCE IMAGING; NERVE BLOCK; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84883497098     PISSN: 10987339     EISSN: 15328651     Source Type: Journal    
DOI: 10.1097/AAP.0b013e31829e52cc     Document Type: Article

References (38)

1. Silvestre-Rangil J, Silvestre FJ, Tamarit-Santafé C, Bautista D. Burning mouth syndrome: Correlation of treatment to clinical variables of the disease. Med Oral Patol Oral Cir Bucal. 2011;16:890-894
2. Spanemberg JC, Cherubini K, de Figueiredo MA, Yurgel LS, Salum FG. Aetiology and therapeutics of burning mouth syndrome: An update. Gerodontology. 2012;29:84-89
3. Sardella A, Uglietti D, Demarosi F, et al. Benzydamine hydrochloride oral rinses in management of burning mouth syndrome. A clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88: 683-686
4. Tammiala-Salonen T, Forssell H. Trazodone in burning mouth pain: A placebo-controlled, double-blind study. J Orofac Pain. 1999;13: 83-88
5. Femiano F, Gombos F, Scully C, Busciolano M, De Luca P. Burning mouth syndrome (BMS): Controlled open trial of the efficacy of alpha-lipoic acid (thioctic acid) on symptomatology. Oral Dis. 2000;6:274-277
6. Femiano F, Scully C. Burning mouth syndrome (BMS): Double blind controlled study of alpha-lipoic acid (thioctic acid) therapy. J Oral Pathol Med. 2002;31:267-269
7. Femiano F. Burning mouth syndrome (BMS): An open trial of comparative efficacy of alpha-lipoic acid (thioctic acid) with other therapies. Minerva Stomatol. 2002;51:405-409
8. Gremeau-Richard C, Woda A, Navez ML, et al. Topical clonazepam in stomatodynia: A randomised placebo-controlled study. Pain. 2004;108:51-57
9. Petruzzi M, Lauritano D, De Benedittis M, Baldoni M, Serpico R. Systemic capsaicin for burning mouth syndrome: Short-Term results of a pilot study. J Oral Pathol Med. 2004;33:111-114
10. Sardella A, Lodi G, Demarosi F, Tarozzi M, Canegallo L, Carrassi A. Hypericum perforatum extract in burning mouth syndrome: A randomized placebo-controlled study. J Oral Pathol Med. 2008;37: 395-401
11. Carbone M, Pentenero M, Carrozzo M, Ippolito A, Gandolfo S. Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: A double-blind, randomized, placebo-controlled study. Eur J Pain. 2009;13:492-496
12. López-Jornet P, Camacho-Alonso F, Leon-Espinosa S. Efficacy of alpha lipoic acid in burning mouth syndrome: A randomized, placebo-Treatment study. J Oral Rehabil. 2009;36:52-57
13. Lopez-D'alessandro E, Escovich L. Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of Burning Mouth Syndrome: A randomized, double-blind, placebo controlled trial. Med Oral Patol Oral Cir Bucal. 2011;16:635-640
14. Heckmann SM, Kirchner E, Grushka M, Wichmann MG, Hummel T. A double-blind study on clonazepam in patients with burning mouth syndrome. Laryngoscope. 2012;122:813-816
15. Silvestre FJ, Silvestre-Rangil J, Tamarit-Santafé C, Bautista D. Application of a capsaicin rinse in the treatment of burning mouth syndrome. Med Oral Patol Oral Cir Bucal. 2012;17:1-4
16. Spanemberg JC, Cherubini K, de Figueiredo MA, Gomes AP, Campos MM, Salum FG. Effect of an herbal compound for treatment of burning mouth syndrome: Randomized, controlled, double-blind clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113:373-377
17. Bogetto B. Psychopharmacological treatment of Burning Mouth Syndrome (BMS). A study sample of 121 patients. Minerva Psichiatr. 1999;40:1-10
18. Bergdahl J, Anneroth G, Perris H. Cognitive therapy in the treatment of patients with resistant burning mouth syndrome: A controlled study. J Oral Pathol Med. 1995;24:213-215
19. Pisanty S, Rafaely B, Polishuk W. The effect of steroid hormones on buccal mucosa of menopausal women. Oral Surg Oral Med Oral Pathol. 1975;40:346-353
20. Wong GY, Gavva NR. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks. Brain Res Rev. 2009;60:267-277
21. Premkumar LS, Sikand P. TRPV1: A target for next generation analgesics. Curr Neuropharmacol. 2008;6:151-163
22. de Moraes M, do Amaral Bezerra BA, da Rocha Neto PC, de Oliveira Soares AC, Pinto LP, de Lisboa Lopes Costa A. Randomized trials for the treatment of burning mouth syndrome: An evidence-based review of the literature. J Oral Pathol Med. 2012;41:281-287
23. Jara-Oseguera A, Simon SA, Rosenbaum T. TRPV1: On the road to pain relief. Curr Mol Pharmacol. 2008;1:255-269
24. Hens MJ, Alonso-Ferreira V, Villaverde-Hueso A, Abaitua I, Posada de la Paz M. Cost-effectiveness analysis of burning mouth syndrome therapy. Community Dent Oral Epidemiol. 2012;40:185-192
25. White TL, Kent PF, Kurtz DB, Emko P. Effectiveness of gabapentin for treatment of burning mouth syndrome. Arch Otolaryngol Head Neck Surg. 2004;130:786-788
26. Rodriguez-Cerdeira C, Sanchez-Blanco E. Treatment of burning mouth syndrome with amisulpride. J Clin Med Res. 2012;4:167-171
27. Maina G, Vitalucci A, Gandolfo S, Bogetto F. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: A single-blind study. J Clin Psychiatry. 2002;63:38-43
28. de Souza FT, Amaral TM, dos Santos TP, et al. Burning mouth syndrome: A therapeutic approach involving mechanical salivary stimulation. Headache. 2012;52:1026-1034
29. Hershkovich O, Nagler RM. Biochemical analysis of saliva and taste acuity evaluation in patients with burning mouth syndrome, xerostomia and/or gustatory disturbances. Arch Oral Biol. 2004;49:515-522
30. Pekiner FN, Demirel GY, Gümrü B, Ozbayrak S. Serum cytokine and T regulatory cell levels in patients with burning mouth syndrome. J Oral Pathol Med. 2008;37:528-534
31. Leung L, Cahill CM. TNF-Alpha and neuropathic pain: A review. J Neuroinflammation. 2010;7:27
32. Yang HW, Huang YF. Treatment of burning mouth syndrome with a low-level energy diode laser. Photomed Laser Surg. 2011;29: 123-125
33. López-Jornet P, Camacho-Alonso F, Andujar-Mateos P. A prospective, randomized study on the efficacy of tongue protector in patients with burning mouth syndrome. Oral Dis. 2011;17:277-282
34. Buchanan J. Tongue protectors for use in burning mouth syndrome?Evid Based Dent. 2012;13:59-60
35. Miziara ID, Filho BC, Oliveira R, Rodrigues dos Santos RM. Group psychotherapy: An additional approach to burning mouth syndrome. J Psychosom Res. 2009;67:443-448
36. Grémeau-Richard C, Dubray C, Aublet-Cuvelier B, Ughetto S, Woda A. Effect of lingual nerve block on burning mouth syndrome (stomatodynia): A randomized crossover trial. Pain. 2010;149:27-32
37. Gibbs J. Commentary: A burning question of subgroup analysis in pain trials. Pain. 2010;149:5-6
38. Formaker BK, Mott AE, Frank ME. The effects of topical anesthesia on oral burning in burning mouth syndrome. Ann N Y Acad Sci. 1998;855:776-780